Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wei, Na ^a   Liu, Stephanie S ^a   Chan, Karen K L ^a   Ngan, Hextan Y S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED CELL DEATH 4 PROTEIN; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE; PDCD4 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; RNA BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL; CANCER CONTROL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; CANCER INVASION; CELL CYCLE; CELL MOTION; CULTURE MEDIUM; DOWN REGULATION; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA-BINDING PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84855860369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030311     Document Type: Article

References (34)

1. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, et al. (1999) Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci U S A 96: 14037-14042.
2. Jansen AP, Camalier CE, Colburn NH, (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65: 6034-6041.
3. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, et al. (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37.
4. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, et al. (2004) A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24: 3894-3906.
5. Zakowicz H, Yang HS, Stark C, Wlodawer A, Laronde-Leblanc N, et al. (2005) Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. Rna 11: 261-274.
6. Goke R, Gregel C, Goke A, Arnold R, Schmidt H, et al. (2004) Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann N Y Acad Sci 1014: 220-221.
7. Goke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B, (2004) Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287: C1541-1546.
8. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, et al. (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306.
9. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, et al. (2006) Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112.
10. Bitomsky N, Wethkamp N, Marikkannu R, Klempnauer KH, (2008) siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression. Oncogene 27: 4820-4829.
11. Lankat-Buttgereit B, Lenschen B, Schmidt H, Goke R, (2008) The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 13: 157-164.
12. Bitomsky N, Bohm M, Klempnauer KH, (2004) Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493.
13. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, et al. (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200: 640-646.
14. Lee S, Bang S, Song K, Lee I, (2006) Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16: 747-754.
15. Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, et al. (2009) miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 31: 642-654.
16. Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagan JP, et al. (2008) Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res 68: 1254-1260.
17. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, et al. (2009) Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 8: 70.
18. Bohm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, et al. (2003) The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22: 4905-4910.
19. Loh PG, Yang HS, Walsh MA, Wang Q, Wang X, et al. (2009) Structural basis for translational inhibition by the tumour suppressor Pdcd4. Embo J 28: 274-285.
20. Jiang Y, Hong Zhang S, Qing Han G, Yong Qin C, (2010) Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma. Biomed Pharmacother.
21. Yang HS, Knies JL, Stark C, Colburn NH, (2003) Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720.
22. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH, (2004) Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23: 8135-8145.
23. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, et al. (2006) S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314: 467-471.
24. Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ, et al. (2009) PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Sci 100: 1408-1413.
25. Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, et al. (2007) Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res 5: 95-108.
26. Hwang SK, Jin H, Kwon JT, Chang SH, Kim TH, et al. (2007) Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 14: 1353-1361.
27. Singh P, Marikkannu R, Bitomsky N, Klempnauer KH, (2009) Disruption of the Pdcd4 tumor suppressor gene in chicken DT40 cells reveals its role in the DNA-damage response. Oncogene 28: 3758-3764.
28. Zhang S, Li J, Jiang Y, Xu Y, Qin C, (2009) Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 28: 71.
29. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, et al. (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166: 297-301.
30. Onishi Y, Hashimoto S, Kizaki H, (1998) Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215: 453-459.
31. Jansen AP, Camalier CE, Stark C, Colburn NH, (2004) Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3: 103-110.
32. Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, et al. (2009) Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res 69: 3148-3156.
33. Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, et al. (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110: 1697-1707.
34. Hwang SK, Minai-Tehrani A, Lim HT, Shin JY, An GH, et al. (2010) Decreased Level of PDCD4 (Programmed Cell Death 4) Protein Activated Cell Proliferation in the Lung of A/J Mouse. J Aerosol Med Pulm Drug Deliv.